Myriad Genetics to Submit Hereditary Cancer Risk Variants to ClinVar in 2023
Myriad Genetics will be contributing to the #ClinVar database starting spring of 2023, including BRCA1 and BRCA2 variants! “Over recent months, Myriad has focused on lifting barriers that have hindered clinicians, health systems, and genetic...
Texas Doctor Pleads Guilty to Role in $54 million Medicare Fraud Scheme including Hereditary Cancer Genetic Testing
“A Texas doctor pleaded guilty today for his role in a $54 million scheme to defraud Medicare by prescribing durable medical equipment and cancer genetic testing without ever seeing, speaking to, or otherwise treating patients.”...
October 2022 – The Data Driven Point of View
Problem: There are systematic problems with accuracy in CLINICAL GENETICS & GENOMICS. Also, accustomed to self-policing, the genetics and genomics lab community express concerns about quality threshold requirements from insurance...
Recent Comments